Bayer loses third trial in claims that Roundup® causes cancer

Gavel on a blue background

Verdicts against Monsanto and its parent company Bayer are beginning to pile up after Monsanto loses its third trial over claims that its weed killer product, Roundup®, causes cancer.

If you have been diagnosed with Non-Hodgkin’s Lymphoma and have a history of using Roundup®, then Bayer and Monsanto may owe you a sizeable amount of money. Monsanto’s weed killer, Roundup®, contains a chemical known as glyphosate which has been linked to a type of cancer called Non-Hodgkin’s Lymphoma.

‘Trial Evidence for the Ohio Practitioner’ CLE seminar scheduled for May 21

Gavel on a blue background.

As part of our Professional Development Series, the Strauss Troy will present an in-house seminar on Tuesday, May 21, beginning at 9:15 a.m. for registration (Breakfast will be served).  The presentation is titled, “Trial Evidence for the Ohio Practitioner” and qualifies for 6.0 CLE Credit Hours.  The presentation qualifies for New Lawyer Training in Ohio.  …Read More

Strauss Troy names Elizabeth Reeder and Stephen Schilling as Shareholders

Strauss Troy congratulates attorneys Elizabeth M. Reeder and Stephen E. Schilling, who have been named Shareholders of the firm. Reeder is a member of the firm’s Corporate|Business and Tax Planning|Compliance groups; Schilling is a member of the Litigation group. Reeder focuses her practice on business and tax law, counseling individuals and businesses from start-ups to established, …Read More

Strauss Troy Listed as a 2019 Best Law Firm by U.S. News – Best Lawyers®

U.S. News Best Law Firms Badge for 2019

U.S. News – Best Lawyers® has recognized Strauss Troy among the Best Law Firms of 2019. Strauss Troy has earned eleven metropolitan rankings and was nationally ranked in Project Finance Law. National Tier 3 Project Finance Law Metropolitan Tier 1 – Cincinnati Commercial Litigation Mass Tort Litigation / Class Actions – Plaintiffs Project Finance Law …Read More

Planning for your family’s future: Is your life insurance sufficient?

It is important to periodically review your life insurance to make sure that you have a policy that will stay in-force long enough to accomplish your estate planning objectives. Recent actions by the life insurance industry to increase costs associated with some policies make it very important to have your insurance reviewed.

Consider if you really need life insurance or if your policy is in danger of imploding. Strauss Troy attorneys can review your current life insurance and assist you if there is a problem with your policy. We can also assist you in evaluating how your policy fits into your current estate plan to ensure that your objectives in providing for your family are met.

Are Onglyza and Kombiglyze XR Related to Heart Failure and Cardiac Arrest?

Stethoscope on prescription pad.

Onglyza (saxaglyptin) and Kombiglyze XR (saxaglyptin/metformin HCl) are prescription medications used to treat Type 2 diabetes. In April 2016, the FDA added new safety warnings to the two medications, indicating that saxaglyptin is associated with an increased risk of heart failure, as well as a higher risk of death from all causes.

Can Prevagen Really Improve Your Memory?

Prevagen, a supplement made by Quincy Bioscience, is one of the most heavily-advertised and expensive supplements on the drugstore shelves today. Prevagen claims in its advertising, and on its label, that the pill can improve memory. If Prevagen could really do that, it might be worth the high price, which is more than $60 for 30 pills of the extra-strength version of the product.

However, recent evidence submitted to a California court raises serious questions about whether Prevagen has any benefit to memory at all.

Financial Advisers Back In Court and Customers Get Caught In The Middle

Late last year, Morgan Stanley and UBS withdrew from the Protocol for Broker Recruiting, followed closely by Citigroup in January. Morgan Stanley and UBS together account for almost half of the approximate 50,000 registered securities representatives (stock brokers) employed by the four major wire houses (Morgan Stanley, UBS, Merrill Lynch, and Wells Fargo).